Insulin signaling and insulin resistance

Journal of Investigative Medicine

Volumn 61, Issue 1, 2013, Pages 11-14

  Beale, Elmus G ^a  

^a Texas Tech University Health Sciences Center El Paso   (United States)

Author keywords

Angiotensin; Cross talk; Insulin resistance; Insulin sensitivity; Metabolic syndrome

Indexed keywords

ADENYLATE KINASE; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; RESISTIN; RETINOL BINDING PROTEIN 4; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL GROWTH; CONFERENCE PAPER; GENE EXPRESSION; GENOTYPE; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; HUNGER; HYPERINSULINEMIA; HYPERTENSION; INSULIN DEFICIENCY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; LIPID METABOLISM; METABOLIC SYNDROME X; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; VASODILATATION;

ANIMALS; CONGRESSES AS TOPIC; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; SIGNAL TRANSDUCTION;

EID: 84873660138     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3182746f95     Document Type: Conference Paper

References (34)

1. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
2. Folli F. Molecular basis of angiotensin-insulin cross-talk. Clues to the understanding of insulin resistance in arterial hypertension. J Investig Med. 2012; In press.
3. Prabhakar S. Inhibition of renin-angiotensin system-implications for diabetes control and prevention. J Investig Med. 2012; In press.
4. Navar LG. Renin and angiotensin system: signaling in health and diabetes. J Investig Med. 2012; In press.
5. Cheng Z, Tseng Y, White MF. Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab. 2010;21:589-598.
6. Shepherd PR. Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues. Acta Physiol Scand. 2005; 183:3-12.
7. Spiegel A, Carter-Su C, Taylor SI, et al. Mechanism of action of hormones that act at the cell surface. In: Melmed S, Polonsky KS, Larsen PR, et al, eds. Williams Textbook of Endocrinology. 12th ed. Philadelphia, PA: Saunders Elsevier; 2011:62-83.
8. Ruderman NB, Xu XJ, Nelson L, et al. AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab. 2010; 298:E751-E760.
9. Thaler JP, Schwartz MW. Minireview: inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology. 2010; 151:4109-4115.
10. Badman MK, Flier JS. The gut and energy balance: visceral allies in the obesity wars. Science. 2005;307:1909-1914.
11. Beale E, Hammer R, Antoine B, et al. Disregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends Endocrinol Metab. 2004;15:129-135.
12. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev. 1998;14:263-283.
13. Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010;375:2267-2277.
14. Leibiger B, Leibiger IB, Moede T, et al. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Mol Cell. 2001;7:559-570.
15. Vigneri R, Squatrito S, Sciacca L. Insulin and its analogs: actions via insulin and IGF receptors. Acta Diabetol. 2010;47:271-278.
16. Sesti G, Federici M, Lauro D, et al. Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms. Diabetes Metab Res Rev. 2001;17:363-373.
17. DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia. 2010;53:1270-1287.
18. Reaven GM. Role of insulin resistance in human-disease (Syndrome-X)Van expanded definition. Annu Rev Med. 1993;44: 121-131.
19. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752.
20. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am. 2004;33:283-303.
21. Steinberger J, Daniels SR, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009;119:628-647.
22. Pratley RE. Gene-environment interactions in the pathogenesis of type 2 diabetes mellitus: lessons learned from the Pima Indians. Proc Nutr Soc. 1998;57:175-181.
23. Stolerman ES, Florez JC. Genomics of type 2 diabetes mellitus: implications for the clinician. Nat Rev Endocrinol. 2009;5:429-436.
24. Muniyappa R, Montagnani M, Koh KK, et al. Cardiovascular actions of insulin. Endocrine Reviews. 2007;28:463-491.
25. Romao I, Roth J. Genetic and environmental interactions in obesity and type 2 diabetes. J Am Diet Assoc. 2008;108:S24-S28.
26. Ahima RS, Lazar MA. Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol. 2008;22:1023-1031.
27. Zac-Varghese S, Tan T, Bloom SR. Hormonal interactions between gut and brain. Discov Med. 2010;10:543-552.
28. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219-246.
29. Huang-Doran I, Sleigh A, Rochford JJ, et al. Lipodystrophy: metabolic insights from a rare disorder. J Endocrinol. 2010;207:245-255.
30. Farooqi IS, O'Rahilly S. Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to obesity. Nat Clin Pract Endocrinol Metab. 2008;4:569-577.
31. Choi JH, Banks AS, Estall JL, et al. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature. 2010;466:451-456.
32. Petrie JR, Pearson ER, Sutherland C. Implications of genome wide association studies for the understanding of type 2 diabetes pathophysiology. Biochem Pharmacol. 2011;81:471-477.
33. Zhou K, Bellenguez C, Spencer CC, et al. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet. 2011;43:117-120.
34. Birnbaum MJ, Shaw RJ. Genomics: drugs, diabetes and cancer. Nature. 2011;470:338-339.